about
Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV InfectionPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsChronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohortHow Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis.Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma.Malignancies and thalassemia: a review of the literature.Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.Tumour-inducing viruses.Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.Anti-hepatocellular carcinoma activity and mechanism of chemopreventive compounds: ursolic acid derivatives.Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area.The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?Evaluation of TRAIL receptor 1 (DR4) Polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular Carcinomas.Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.Viral Oncology: Molecular Biology and Pathogenesis.Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.Pathways of topological rank analysis (PoTRA): a novel method to detect pathways involved in hepatocellular carcinoma.Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals.Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol.Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma'It's been a long haul, a big haul, but we've made it': hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysis
P2860
Q26766689-4162F1BB-1F3B-4268-9961-2259AB82D48BQ26784252-292ABC46-F839-4F6C-8665-377D502B097EQ28076161-7D36E847-AF60-42AE-ACED-348B64602A20Q33747227-2EF4DA63-9DA6-4F4E-91DC-0969ECDC009AQ36001469-BB84DA08-0B78-4884-BC34-2F159FE56662Q36854662-3A988549-5DCE-4B99-BEE4-2711E28C32B8Q37399410-8D8AD9ED-2810-4F01-921E-7A0300B8A429Q37742979-198A0697-52FC-4052-80DB-5F254B34B10CQ38375370-B88C5E44-D377-4059-B140-B58CE4F24964Q38750541-480ED18A-8506-412A-A522-768182AF9076Q38802155-F3D92D8B-C7A6-4B2F-9E0C-AC5DF16E2DF9Q38977066-060F4DC1-1179-4AE3-B196-A3018ADC95E4Q38980732-C116A3C1-6FE8-42A7-B0E3-2623BDD4BF21Q39030356-E9077225-BFE1-436A-AD2B-9FE1737B2960Q39148859-ABEE70DC-5660-47CB-99B1-E99869A75B0FQ39253341-741CEB91-B738-42E5-8085-ABBD43508CACQ39450856-FBD362EC-6437-4CF2-84DA-27CC85B5947BQ40084423-F6264A3F-B170-437F-B600-2BAE6798A616Q40522226-68BBAD94-CD09-485A-8316-84BF77769433Q41924906-D8265C6A-017C-4B1E-A2CA-DD78E986DC2DQ45325263-6F5088C9-D414-4568-9EA0-58DE5DF826A6Q47550120-8489F1A9-30ED-4CB5-BF5E-583DDA513712Q47571734-BFC411D6-8706-4918-AB95-15B2865F0546Q47601762-813D9037-1C33-481F-9A00-46EAB929A3ACQ52318559-9A985D75-E1BD-4C42-A77A-D4EDE4E699BEQ52661697-BE3D29EE-8036-4FFF-B148-E9A43309EE61Q54230120-1DB09E97-F2D4-4A43-9BB2-99EB7071E819Q55359512-DF30477E-6B3D-4780-BD81-02F21E865DC2Q57152054-BD3B3609-5311-4D89-B559-7357CE608ACDQ58799482-019C4186-6CE9-45ED-9575-6BC01A45D284
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hepatitis C virus-induced hepatocellular carcinoma
@ast
Hepatitis C virus-induced hepatocellular carcinoma
@en
type
label
Hepatitis C virus-induced hepatocellular carcinoma
@ast
Hepatitis C virus-induced hepatocellular carcinoma
@en
prefLabel
Hepatitis C virus-induced hepatocellular carcinoma
@ast
Hepatitis C virus-induced hepatocellular carcinoma
@en
P2860
P921
P1476
Hepatitis C virus-induced hepatocellular carcinoma
@en
P2093
Nicolas Goossens
Yujin Hoshida
P2860
P304
P356
10.3350/CMH.2015.21.2.105
P5008
P577
2015-06-01T00:00:00Z
2015-06-26T00:00:00Z